Zymeworks (ZYME) Cash from Operations (2021 - 2026)
Zymeworks (ZYME) posted Cash from Operations of 45718000.0 for Q1 2026, down 345.64% sequentially from 10259000.0 in Q4 2025, and down 1241.88% YoY from 4003732.93 in Q1 2025.
Powered by 
Analysis
Zymeworks (ZYME) Cash from Operations (2021 - 2026) Analysis & Trends
Zymeworks has reported Cash from Operations for 6 years, with the latest figure at 45718000.0 in Q1 2026.
- Quarterly Cash from Operations fell 1241.88% year-over-year to 45718000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 75316000.0 (up 0.63% YoY) and the FY2025 annual result came in at 33005000.0, up 70.01% from the prior year.
- Cash from Operations eased to 45718000.0 in Q1 2026 per ZYME's latest filing, from 10259000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 327360000.0 in Q4 2022 and troughed at 83191000.0 in Q1 2023.
- A 5-year average of 9588000.0 and a median of 31412000.0 in 2025 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2026: Cash from Operations soared 748.12% in 2022, then plunged 1241.88% in 2026.
- Over 5 years, Cash from Operations stood at 327360000.0 in 2022, then slumped by 95.74% to 13933000.0 in 2023, then sank by 397.93% to 41510000.0 in 2024, then soared by 75.29% to 10259000.0 in 2025, then sank by 345.64% to 45718000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 45718000.0, 10259000.0, and 31412000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Zymeworks | 2.13 Bn | 1.86 Bn | - | -31.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.95 Mn |
| Mar 31, 2026 | -45.72 Mn |
| Dec 31, 2025 | -10.26 Mn |
| Sep 30, 2025 | -31.41 Mn |
| Jun 30, 2025 | 12.07 Mn |
| Mar 31, 2025 | -3.41 Mn |
| Dec 31, 2024 | -41.51 Mn |
| Sep 30, 2024 | -5.88 Mn |
| Jun 30, 2024 | -24.99 Mn |
| Mar 31, 2024 | -37.68 Mn |
| Dec 31, 2023 | 13.93 Mn |
| Sep 30, 2023 | -42.67 Mn |
| Jun 30, 2023 | -6.40 Mn |
| Mar 31, 2023 | -83.19 Mn |
| Dec 31, 2022 | 327.36 Mn |
| Sep 30, 2022 | -73.02 Mn |
| Jun 30, 2022 | -54.82 Mn |
| Mar 31, 2022 | -55.41 Mn |
| Dec 31, 2021 | -50.51 Mn |